Spironolactone (Spironolactone)


Indications and Reactions:

Role Indications Reactions
Secondary
Product Used For Unknown Indication 68.6%
Hypertension 8.6%
Cardiac Failure 2.9%
Cardiac Failure Congestive 2.9%
Cardiomyopathy 2.9%
Atrial Fibrillation 1.9%
Renal Transplant 1.9%
Type 1 Diabetes Mellitus 1.9%
Type 2 Diabetes Mellitus 1.9%
Urinary Tract Infection 1.9%
Amyloidosis 1.0%
Depression 1.0%
Elective Surgery 1.0%
Oesophagitis 1.0%
Prophylaxis Urinary Tract Infection 1.0%
Renal Failure Acute 22.2%
International Normalised Ratio Increased 11.1%
Blood Glucose Fluctuation 3.7%
Cardiac Procedure Complication 3.7%
Drug Interaction 3.7%
Drug Reaction With Eosinophilia And Systemic Symptoms 3.7%
Dry Mouth 3.7%
Hypertension 3.7%
Hypotension 3.7%
Hypothermia 3.7%
Metabolic Acidosis 3.7%
Overdose 3.7%
Pain In Extremity 3.7%
Presyncope 3.7%
Rash 3.7%
Rectal Haemorrhage 3.7%
Red Man Syndrome 3.7%
Renal Failure 3.7%
Respiratory Rate Increased 3.7%
Rhabdomyolysis 3.7%
Concomitant
Product Used For Unknown Indication 20.2%
Plasma Cell Myeloma 10.5%
Multiple Sclerosis 9.6%
Chronic Myeloid Leukaemia 5.3%
Pneumonia 5.3%
Depression 4.4%
Gait Disturbance 4.4%
Immunodeficiency Common Variable 4.4%
Acromegaly 3.5%
Cellulitis 3.5%
Colorectal Cancer 3.5%
Colorectal Cancer Metastatic 3.5%
Hypertension 3.5%
Breast Cancer 2.6%
Cancer Pain 2.6%
Myelodysplastic Syndrome 2.6%
Peritonitis Bacterial 2.6%
Status Epilepticus 2.6%
Type 2 Diabetes Mellitus 2.6%
Urinary Incontinence 2.6%
Vomiting 9.8%
Nausea 7.8%
Restless Legs Syndrome 7.8%
Urinary Tract Infection 7.8%
White Blood Cell Count Decreased 7.8%
Anaemia 3.9%
Herpes Zoster 3.9%
Hip Fracture 3.9%
Macular Oedema 3.9%
Megacolon 3.9%
Pulmonary Embolism 3.9%
Pulmonary Oedema 3.9%
Renal Failure 3.9%
Renal Failure Acute 3.9%
Renal Impairment 3.9%
Somnolence 3.9%
Tardive Dyskinesia 3.9%
Treatment Failure 3.9%
Unresponsive To Stimuli 3.9%
Ventricular Tachycardia 3.9%

Drug Data